{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T12:10:06Z","timestamp":1744027806881,"version":"3.40.3"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T00:00:00Z","timestamp":1743984000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T00:00:00Z","timestamp":1743984000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Youth Pre-Research Fund of the Second Affiliated Hospital of Soochow University"},{"name":"Youth Pre-Research Fund of the Second Affiliated Hospital of Soochow University"},{"name":"Suzhou \"Science and Education Rejuvenating Health\" Youth Science and Technology Project"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-025-02249-0","type":"journal-article","created":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T11:46:55Z","timestamp":1744026415000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Causal role of immune cells in thyroid cancer: a two-sample Mendelian randomization study"],"prefix":"10.1007","volume":"16","author":[{"given":"Shurong","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhouyu","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenjin","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yueyue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhihua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,7]]},"reference":[{"key":"2249_CR1","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/S2213-8587(21)00027-9","volume":"9","author":"A Miranda-Filho","year":"2021","unstructured":"Miranda-Filho A, Lortet-Tieulent J, Bray F, et al. Thyroid cancer incidence trends by histology in 25 countries: a population-based study. Lancet Diabetes Endocrinol. 2021;9:225\u201334. https:\/\/doi.org\/10.1016\/S2213-8587(21)00027-9.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2249_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/thy.2015.0020","volume":"26","author":"BR Haugen","year":"2016","unstructured":"Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2016;26:1\u2013133. https:\/\/doi.org\/10.1089\/thy.2015.0020.","journal-title":"Thyroid"},{"key":"2249_CR3","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1001\/jamaoncol.2019.6851","volume":"6","author":"AS Ho","year":"2020","unstructured":"Ho AS, Luu M, Barrios L, et al. Incidence and mortality risk spectrum across aggressive variants of papillary thyroid carcinoma. JAMA Oncol. 2020;6:706. https:\/\/doi.org\/10.1001\/jamaoncol.2019.6851.","journal-title":"JAMA Oncol"},{"key":"2249_CR4","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s12943-018-0903-0","volume":"17","author":"S Saini","year":"2018","unstructured":"Saini S, Tulla K, Maker AV, et al. Therapeutic advances in anaplastic thyroid cancer: a current perspective. Mol Cancer. 2018;17:154. https:\/\/doi.org\/10.1186\/s12943-018-0903-0.","journal-title":"Mol Cancer"},{"key":"2249_CR5","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1089\/thy.2018.0509","volume":"29","author":"T Ibrahimpasic","year":"2019","unstructured":"Ibrahimpasic T, Ghossein R, Shah JP, Ganly I. Poorly differentiated carcinoma of the thyroid gland: current status and future prospects. Thyroid. 2019;29:311\u201321. https:\/\/doi.org\/10.1089\/thy.2018.0509.","journal-title":"Thyroid"},{"key":"2249_CR6","doi-asserted-by":"publisher","first-page":"4413","DOI":"10.3390\/ijms20184413","volume":"20","author":"F Ferrari","year":"2019","unstructured":"Ferrari F, FallahiGaldiero PMR, et al. Immune and inflammatory cells in thyroid cancer microenvironment. Int J Mol Sci. 2019;20:4413. https:\/\/doi.org\/10.3390\/ijms20184413.","journal-title":"Int J Mol Sci"},{"key":"2249_CR7","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1126\/science.aaa6204","volume":"348","author":"JA Joyce","year":"2015","unstructured":"Joyce JA, Fearon DT. T cell exclusion, immune privilege, and the tumor microenvironment. Science. 2015;348:74\u201380. https:\/\/doi.org\/10.1126\/science.aaa6204.","journal-title":"Science"},{"key":"2249_CR8","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.semcancer.2019.05.019","volume":"64","author":"SM Ferrari","year":"2020","unstructured":"Ferrari SM, Fallahi P, Elia G, et al. Thyroid autoimmune disorders and cancer. Semin Cancer Biol. 2020;64:135\u201346. https:\/\/doi.org\/10.1016\/j.semcancer.2019.05.019.","journal-title":"Semin Cancer Biol"},{"key":"2249_CR9","doi-asserted-by":"publisher","first-page":"3934","DOI":"10.3390\/ijms20163934","volume":"20","author":"G Varricchi","year":"2019","unstructured":"Varricchi G, Loffredo S, Marone G, et al. the immune landscape of thyroid cancer in the context of immune checkpoint inhibition. Int J Mol Sci. 2019;20:3934. https:\/\/doi.org\/10.3390\/ijms20163934.","journal-title":"Int J Mol Sci"},{"key":"2249_CR10","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1080\/08916930310001603046","volume":"36","author":"RA Ajjan","year":"2003","unstructured":"Ajjan RA, Weetman AP. Cytokines in thyroid autoimmunity. Autoimmunity. 2003;36:351\u20139. https:\/\/doi.org\/10.1080\/08916930310001603046.","journal-title":"Autoimmunity"},{"key":"2249_CR11","doi-asserted-by":"publisher","first-page":"14273","DOI":"10.1038\/srep14273","volume":"5","author":"A Yuan","year":"2015","unstructured":"Yuan A, Hsiao Y-J, Chen H-Y, et al. Opposite effects of M1 and M2 macrophage subtypes on lung cancer progression. Sci Rep. 2015;5:14273. https:\/\/doi.org\/10.1038\/srep14273.","journal-title":"Sci Rep"},{"key":"2249_CR12","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1089\/104303403322611755","volume":"14","author":"Y Shi","year":"2003","unstructured":"Shi Y, Parhar RS, Zou M, et al. Gene therapy of anaplastic thyroid carcinoma with a single-chain interleukin-12 fusion protein. Hum Gene Ther. 2003;14:1741\u201351. https:\/\/doi.org\/10.1089\/104303403322611755.","journal-title":"Hum Gene Ther"},{"key":"2249_CR13","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1038\/s41588-020-0684-4","volume":"52","author":"V Orr\u00f9","year":"2020","unstructured":"Orr\u00f9 V, Steri M, Sidore C, et al. Complex genetic signatures in immune cells underlie autoimmunity and inform therapy. Nat Genet. 2020;52:1036\u201345. https:\/\/doi.org\/10.1038\/s41588-020-0684-4.","journal-title":"Nat Genet"},{"key":"2249_CR14","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1038\/ng.3368","volume":"47","author":"C Sidore","year":"2015","unstructured":"Sidore C, et al. Genome sequencing elucidates Sardinian genetic architecture and augments association analyses for lipid and blood inflammatory markers. Nat Genet. 2015;47:1272\u201381.","journal-title":"Nat Genet"},{"key":"2249_CR15","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1016\/j.joca.2021.08.003","volume":"29","author":"X-H Yu","year":"2021","unstructured":"Yu X-H, Yang Y-Q, Cao R-R, et al. The causal role of gut microbiota in development of osteoarthritis. Osteoarthritis Cartilage. 2021;29:1741\u201350. https:\/\/doi.org\/10.1016\/j.joca.2021.08.003.","journal-title":"Osteoarthritis Cartilage"},{"key":"2249_CR16","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/nature15393","volume":"526","author":"A Auton","year":"2015","unstructured":"The 1000 Genomes Project Consortium, Auton A, et al. A global reference for human genetic variation. Nature. 2015;526:68\u201374. https:\/\/doi.org\/10.1038\/nature15393.","journal-title":"Nature"},{"key":"2249_CR17","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1177\/0962280215597579","volume":"26","author":"S Burgess","year":"2017","unstructured":"Burgess S, Small DS, Thompson SG. A review of instrumental variable estimators for Mendelian randomization. Stat Methods Med Res. 2017;26:2333\u201355. https:\/\/doi.org\/10.1177\/0962280215597579.","journal-title":"Stat Methods Med Res"},{"key":"2249_CR18","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/gepi.21965","volume":"40","author":"J Bowden","year":"2016","unstructured":"Bowden J, Davey Smith G, Haycock PC, Burgess S. Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator. Genet Epidemiol. 2016;40:304\u201314. https:\/\/doi.org\/10.1002\/gepi.21965.","journal-title":"Genet Epidemiol"},{"key":"2249_CR19","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s10654-017-0255-x","volume":"32","author":"S Burgess","year":"2017","unstructured":"Burgess S, Thompson SG. Interpreting findings from Mendelian randomization using the MR-Egger method. Eur J Epidemiol. 2017;32:377\u201389. https:\/\/doi.org\/10.1007\/s10654-017-0255-x.","journal-title":"Eur J Epidemiol"},{"key":"2249_CR20","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","volume":"50","author":"M Verbanck","year":"2018","unstructured":"Verbanck M. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat Genet. 2018;50:693\u20138.","journal-title":"Nat Genet"},{"key":"2249_CR21","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-000860","volume":"8","author":"F Zammarchi","year":"2020","unstructured":"Zammarchi F, Havenith K, Bertelli F, et al. CD25-targeted antibody\u2013drug conjugate depletes regulatory T cells and eliminates established syngeneic tumors via antitumor immunity. J Immunother Cancer. 2020;8: e000860. https:\/\/doi.org\/10.1136\/jitc-2020-000860.","journal-title":"J Immunother Cancer"},{"key":"2249_CR22","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1002\/ijc.34281","volume":"152","author":"Y Peng","year":"2023","unstructured":"Peng Y, Tao Y, Zhang Y, et al. CD25: a potential tumor therapeutic target. Int J Cancer. 2023;152:1290\u2013303. https:\/\/doi.org\/10.1002\/ijc.34281.","journal-title":"Int J Cancer"},{"key":"2249_CR23","doi-asserted-by":"publisher","DOI":"10.1101\/2023.03.13.532151","author":"J Lee","year":"2023","unstructured":"Lee J, Robinson ME, Sun R, et al. Dynamic phosphatase-recruitment controls B-cell selection and oncogenic signaling. bioRxiv. 2023. https:\/\/doi.org\/10.1101\/2023.03.13.532151.","journal-title":"bioRxiv"},{"key":"2249_CR24","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1111\/j.1600-0897.2005.00330.x","volume":"54","author":"B Barnett","year":"2005","unstructured":"Barnett B, Kryczek I, Cheng P, et al. Regulatory T cells in ovarian cancer: biology and therapeutic potential. Am J Reprod Immunol. 2005;54:369\u201377. https:\/\/doi.org\/10.1111\/j.1600-0897.2005.00330.x.","journal-title":"Am J Reprod Immunol"},{"key":"2249_CR25","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1007\/s10555-014-9529-x","volume":"33","author":"EC Halvorsen","year":"2014","unstructured":"Halvorsen EC, Mahmoud SM, Bennewith KL. Emerging roles of regulatory T cells in tumour progression and metastasis. Cancer Metastasis Rev. 2014;33:1025\u201341. https:\/\/doi.org\/10.1007\/s10555-014-9529-x.","journal-title":"Cancer Metastasis Rev"},{"key":"2249_CR26","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1210\/jc.2009-2564","volume":"95","author":"JD French","year":"2010","unstructured":"French JD, Weber ZJ, Fretwell DL, et al. Tumor-associated lymphocytes and increased FoxP3+ regulatory T cell frequency correlate with more aggressive papillary thyroid cancer. J Clin Endocrinol Metab. 2010;95:2325\u201333. https:\/\/doi.org\/10.1210\/jc.2009-2564.","journal-title":"J Clin Endocrinol Metab"},{"key":"2249_CR27","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1016\/j.trecan.2022.06.008","volume":"8","author":"F Shan","year":"2022","unstructured":"Shan F, Somasundaram A, Bruno TC, et al. Therapeutic targeting of regulatory T cells in cancer. Trends Cancer. 2022;8:944\u201361. https:\/\/doi.org\/10.1016\/j.trecan.2022.06.008.","journal-title":"Trends Cancer"},{"key":"2249_CR28","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1136\/gutjnl-2011-300970","volume":"61","author":"G Betts","year":"2012","unstructured":"Betts G, Jones E, Junaid S, et al. Suppression of tumour-specific CD4+ T cells by regulatory T cells is associated with progression of human colorectal cancer. Gut. 2012;61:1163\u201371. https:\/\/doi.org\/10.1136\/gutjnl-2011-300970.","journal-title":"Gut"},{"key":"2249_CR29","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/JLB.3RU0420-668RR","volume":"109","author":"SA Erokhina","year":"2021","unstructured":"Erokhina SA, Streltsova MA, Kanevskiy LM, et al. HLA-DR-expressing NK cells: effective killers suspected for antigen presentation. J Leukoc Biol. 2021;109:327\u201337. https:\/\/doi.org\/10.1002\/JLB.3RU0420-668RR.","journal-title":"J Leukoc Biol"},{"key":"2249_CR30","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/nri3383","volume":"13","author":"A Cerutti","year":"2013","unstructured":"Cerutti A, Cols M, Puga I. Marginal zone B cells: virtues of innate-like antibody-producing lymphocytes. Nat Rev Immunol. 2013;13:118\u201332. https:\/\/doi.org\/10.1038\/nri3383.","journal-title":"Nat Rev Immunol"},{"key":"2249_CR31","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1158\/0008-5472.CAN-16-2684","volume":"78","author":"FP Canale","year":"2018","unstructured":"Canale FP, Ramello MC, N\u00fa\u00f1ez N, et al. CD39 expression defines cell exhaustion in tumor-infiltrating CD8+ T cells. Cancer Res. 2018;78:115\u201328. https:\/\/doi.org\/10.1158\/0008-5472.CAN-16-2684.","journal-title":"Cancer Res"},{"key":"2249_CR32","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1007\/s00262-020-02563-2","volume":"69","author":"Y Qi","year":"2020","unstructured":"Qi Y, Xia Y, Lin Z, et al. Tumor-infiltrating CD39+CD8+ T cells determine poor prognosis and immune evasion in clear cell renal cell carcinoma patients. Cancer Immunol Immunother. 2020;69:1565\u201376. https:\/\/doi.org\/10.1007\/s00262-020-02563-2.","journal-title":"Cancer Immunol Immunother"},{"key":"2249_CR33","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.immuni.2019.11.014","volume":"52","author":"AR Cillo","year":"2020","unstructured":"Cillo AR, K\u00fcrten CHL, Tabib T, et al. Immune landscape of viral- and carcinogen-driven head and neck cancer. Immunity. 2020;52:183-199.e9. https:\/\/doi.org\/10.1016\/j.immuni.2019.11.014.","journal-title":"Immunity"},{"key":"2249_CR34","doi-asserted-by":"publisher","first-page":"5994","DOI":"10.1158\/1078-0432.CCR-12-3497","volume":"19","author":"J-Y Shi","year":"2013","unstructured":"Shi J-Y, Gao Q, Wang Z-C, et al. Margin-infiltrating CD20+ B cells display an atypical memory phenotype and correlate with favorable prognosis in hepatocellular carcinoma. Clin Cancer Res. 2013;19:5994\u20136005. https:\/\/doi.org\/10.1158\/1078-0432.CCR-12-3497.","journal-title":"Clin Cancer Res"},{"key":"2249_CR35","doi-asserted-by":"publisher","first-page":"S17","DOI":"10.4103\/0971-5916.191743","volume":"143","author":"A Saksena","year":"2016","unstructured":"Saksena A, Gautam P, Desai P, et al. Side scatter versus CD45 flow cytometric plot can distinguish acute leukaemia subtypes. Indian J Med Res. 2016;143:S17\u201322. https:\/\/doi.org\/10.4103\/0971-5916.191743.","journal-title":"Indian J Med Res"},{"key":"2249_CR36","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1093\/labmed\/lmz085","volume":"51","author":"M Sorigue","year":"2020","unstructured":"Sorigue M, Santos-Gomez M, Comes M, et al. Flow cytometry in the differential diagnosis of CD10-positive nodal lymphomas. Lab Med. 2020;51:385\u201393. https:\/\/doi.org\/10.1093\/labmed\/lmz085.","journal-title":"Lab Med"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-02249-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-02249-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-02249-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T11:46:55Z","timestamp":1744026415000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-025-02249-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,7]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2249"],"URL":"https:\/\/doi.org\/10.1007\/s12672-025-02249-0","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,7]]},"assertion":[{"value":"7 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The research was conducted in accordance with ethical guidelines and principles. All data used in this study came from publicly available sources, and no human or animal subjects were directly involved in this study, thus ethical approval and consent to participate were not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All the authors agreed to publish the manuscript. We confirm that the manuscript represents original work and has not been published or submitted for publication elsewhere.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"481"}}